lubricants and moisturisers can be used in atrophic vaginitis
may be effective in treatment of dyspareunia in women with mild to moderate vaginal dryness
useful if contraindication to oestrogen/women does not want to use oestrogen
atrophic vaginitis may respond to a short course of vaginal oestrogen and may be required in addition to oral or transdermal HRT (see linked item). The usual dose is daily for two weeks and then twice weekly for up to three months
if only vaginal symptoms and no menopausal symptoms then vaginal oestrogen is often used (rather than systemic HRT)
approximately 10-25% of women receiving HRT will continue to have symptoms of atrophic vaginitis
these women may require topical oestrogen in addition to HRT
ospemifene is an alternative treatment for atrophic vaginitis
Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.